 OUTLINE: This is a randomized, double-blind, placebo-controlled, parallel group, multicenter study. Patients are stratified according to age 60 years vs 60 years and duration of first complete response CR or CR with platelet count 100,000mm3 but 20,000mm3 transfusion independent for 7 consecutive days CRp 12 months vs 12 months. 